Al's Comment:

 This is an exciting new drug that targets EGFR mutations and is brain penetrant.   I doubt if this drug by itself will be the cure, but it will probably help a lot, and may be a part of the ultimate cocktail that is the cure.  

Posted on: 04/20/2022

Black Diamond Therapeutics Announces First Patient Dosed in Phase 1 Study of BDTX-1535, a MasterKey Inhibitor of EGFR for the Treatment of Glioblastoma and Non-Small Cell Lung Cancer


Click HERE to return to brain tumor news headlines.

Our privacy / cookie policy has changed.
Click HERE to read it!